Tri-City Medical Center, founded in 1961, is a full-service, acute-care public hospital in Oceanside, California. Located 40 miles north of San Diego, Tri-City serves three major cities in the North County section of San Diego County: Oceanside, Vista, and Carlsbad.

During the past decade, Tri-City Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tri-City Medical Center" #1 sponsor was "Alexion" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Applied Spine Technologies" with 1 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored and "Cook Group Incorporated" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tri-City Medical Center" #1 collaborator was "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Cook Japan Incorporated" with 1 trials as a collaborator, "Icad, Inc." with 1 trials as a collaborator, "MED Institute, Incorporated" with 1 trials as a collaborator and "Procter and Gamble" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Tri-City Medical Center" are "Peripheral Vascular Diseases" (2 trials), "Acute Ischemic Stroke" (1 trials), "Bacterial Skin Diseases" (1 trials), "Cardio-pulmonary Bypass" (1 trials) and "Complicated Urinary Tract Infection" (1 trials). Many other conditions were trialed in "Tri-City Medical Center" in a lesser frequency.

Most popular intervention types in "Tri-City Medical Center" are "Drug" (6 trials), "Device" (5 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Angioplasty" (1 trials), "Ceftriaxone and amoxicillin/clavulanate" (1 trials), "Imipenem/Cilastatin" (1 trials), "Intra-operative Radiation Therapy - IORT" (1 trials) and "NXL104/ceftazidime" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tri-City Medical Center" are 10 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Tri-City Medical Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Tri-City Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tri-City Medical Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".